Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Naoyasu Umeda"'
Autor:
Yuji Oshima, Yumi Ishibashi, Naoyasu Umeda, Tatsuo Nagata, Shigeo Yoshida, Eiichi Uchio, Hiroyuki Kondo, Koh-hei Sonoda, Tatsuro Ishibashi
Publikováno v:
BMC Ophthalmology, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background To evaluate the correlation between visual acuity improvement and vision-related QOL after ranibizumab treatment in Japanese patients with AMD. Methods In this one-year prospective, interventional, open-label, multicenter study in
Externí odkaz:
https://doaj.org/article/6ebbc80aea92409a90b111e5ca604436
Autor:
Shigeo Yoshida, Tatsuo Nagata, Koh Hei Sonoda, Yuji Oshima, Eiichi Uchio, Tatsuro Ishibashi, Naoyasu Umeda, Yumi Ishibashi, Hiroyuki Kondo
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Ophthalmology, Vol 21, Iss 1, Pp 1-11 (2021)
Background To evaluate the correlation between visual acuity improvement and vision-related QOL after ranibizumab treatment in Japanese patients with AMD. Methods In this one-year prospective, interventional, open-label, multicenter study involving f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f072a45c9479b7eff4500501b03c8f9d
https://doi.org/10.1186/s12886-021-01816-7
https://doi.org/10.1186/s12886-021-01816-7
Autor:
Yuji Oshima, Yumi Ishibashi, Naoyasu Umeda, Tatsuo Nagata, Shigeo Yoshida, Eiichi Uchio, Hiroyuki Kondo, Koh-hei Sonoda, Tatsuro Ishibashi
Background: To evaluate the correlation between visual acuity improvement and vision-related QOL after ranibizumab treatment in Japanese patients with AMD.Methods: In this one-year prospective, interventional, open-label, multicenter study involving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e242c5acc87e4b6de331a860a9f0e1a7
https://doi.org/10.21203/rs.3.rs-116089/v1
https://doi.org/10.21203/rs.3.rs-116089/v1
Publikováno v:
Nippon Ganka Gakkai zasshi. 119(12)
To compare pro re nata (PRN) intravitreal injections of aflibercept (IVA) and ranibizumab (IVR) in patients with treatment naïve age-related macular degeneration (AMD).We analyzed 42 eyes that receive 3 times monthly IVA as introduction phase and su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cd9404269213a7c0c9964499fbd3f969
https://pubmed.ncbi.nlm.nih.gov/26817131
https://pubmed.ncbi.nlm.nih.gov/26817131
Autor:
S. Iqball, Naoyasu Umeda, Shu Kachi, Katsutoshi Yokoi, Peter A. Campochiaro, Katie Binley, Daisuke Muramatu, O. Kan, Hideo Akiyama, Stuart Naylor
Publikováno v:
Human Gene Therapy. 20:31-39
Equine infectious anemia virus (EIAV) is a nonprimate lentivirus that does not cause human disease. Subretinal injection into mice of a recombinant EIAV lentiviral vector in which lacZ is driven by a CMV promoter (EIAV CMV LacZ) resulted in rapid and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3723bd7b1a3e3ab85e651fe1dc8a9ddd
https://doi.org/10.1089/hum.2008.046
https://doi.org/10.1089/hum.2008.046
Autor:
Jon Cao, Naoyasu Umeda, Shu Kachi, Katsutoshi Yokoi, Dellamary Luis A, Betty Tam, John Doukas, Adrienne Racanelli-Layton, Michael D. Martin, Hideo Akiyama, Zoe Chen, Sankaranarayana Pillai Mahesh, Peter A. Campochiaro, Glenn Noronha, Richard Soll, John Hood
Publikováno v:
Journal of Cellular Physiology. 216:29-37
Age-related macular degeneration, diabetic retinopathy, and retinal vein occlusions are complicated by neovascularization and macular edema. Multi-targeted kinase inhibitors that inhibit select growth factor receptor tyrosine kinases and/or component
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c41fe9c637c4fbadbc0bab0c4a181cb3
https://doi.org/10.1002/jcp.21426
https://doi.org/10.1002/jcp.21426
Autor:
Hideo Akiyama, Naoyasu Umeda, Peter A. Campochiaro, Roland Stragies, Grit Zahn, Shu Kachi, Doerte Vossmeyer
Publikováno v:
Molecular Pharmacology. 69:1820-1828
Integrin alpha(5)beta(1) plays an important role in developmental angiogenesis, but its role in various types of pathologic neovascularization has not been completely defined. In this study, we found strong up-regulation of alpha(5)beta(1) in choroid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4624dd987e04c97b19b3f43066dcf326
https://doi.org/10.1124/mol.105.020941
https://doi.org/10.1124/mol.105.020941
Autor:
Khalid A. Mohamedali, Sadia Aslam, Christina Hatara, Shu Kachi, Ji Kui Shen, Hong Lai, Michael G. Rosenblum, Sean F. Hackett, Naoyasu Umeda, Melissa Krause, Raquel Lima e Silva, Hideo Akiyama, Peter A. Campochiaro
Publikováno v:
Molecular Pharmacology. 68:1543-1550
Tumors provide an extremely abnormal microenvironment that stimulates neovascularization from surrounding vessels and causes altered gene expression within vascular cells. Up-regulation of vascular endothelial growth factor (VEGF) receptors has allow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc08f599d126697fcdab39c6a8e02da5
https://doi.org/10.1124/mol.105.015628
https://doi.org/10.1124/mol.105.015628
Publikováno v:
American Journal of Ophthalmology. 138:270-279
Purpose To determine whether ephrinB2 plays a role in ocular angiogenesis, we investigated the expression of ephrinB2 and EphB receptors on retinal fibroproliferative membranes. Design Experimental study of the expression of ephrinB2 and EphB recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70c8fe6cb67c973662e5b105906496b3
https://doi.org/10.1016/j.ajo.2004.04.006
https://doi.org/10.1016/j.ajo.2004.04.006
Publikováno v:
Ophthalmic Research. 35:217-223
Purpose: The tyrosine kinase receptor Tie2 and its ligands, the angiopoietins (Angs), play important roles in vascular integrity and neovascularization, modulating vascular endothelial growth factor (VEGF) activity. To elucidate the potential role of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::924e184a012b22318be1a0e8edde7f20
https://doi.org/10.1159/000071173
https://doi.org/10.1159/000071173